<DOC>
	<DOCNO>NCT01306292</DOCNO>
	<brief_summary>This intra-subject crossover comparative safety study evaluate effect intravenous ( IV ) bolus injection SonoVue pulmonary hemodynamics .</brief_summary>
	<brief_title>Safety SonoVue Pulmonary Hemodynamics</brief_title>
	<detailed_description>Subjects divide two group base baseline mean pulmonary arterial pressure . Each subject receive two injection randomize order right heart catheterization : one administration SonoVue one administration placebo , either SonoVue follow Placebo Placebo follow SonoVue . The purpose provide direct evidence presence absence pulmonary hemodynamic effect follow IV administration SonoVue versus effect follow IV administration volume placebo .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Provides write informed consent male female least 18 year age schedule undergo right heart catheterization clinical reason Pregnant lactate female Significant arrhythmia nonsinus rhythm may affect ability assess pulmonary hemodynamics catheterization Known allergy one ingredient investigational product contrast agent include ultrasound contrast agent Previously enter study receive investigational compound within 30 day admission study Unstable pulmonary and/or systemic hemodynamic condition would affect ability evaluate pharmacological hemodynamic effect investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>Right heart Catheterization</keyword>
</DOC>